Gilead said it has completed its $7.8 billion acquisition of Arcellx, a deal the company hopes will allow it to streamline and accelerate the…

Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…

The U.S. Food and Drug Administration (FDA) has named Terns Pharmaceuticals’ investigational oral agent TERN-701 a breakthrough therapy for potential use in certain people…